President Trump’s claims that deregulation has greatly helped the economy are exaggerated.
ACUS collaborated with agency officials to identify inefficiencies in the PRA approval process.
A one-size-fits-all approach to cost-benefit analysis won’t necessarily ensure better policy.
President Trump’s first year in office prompts four steps for reform.
The Trump Administration’s purported economic justification weakens the credibility of cost-benefit analysis.
The Trump Administration’s information request violates a longstanding federal law.
The Trump Administration’s embrace of a seldom-used law may undermine future regulatory efforts.
Earlier and less burdensome regulatory impact analyses would lead to more transparent, better regulatory decisions.
Combining better analysis with more meaningful participation will improve policy decisions.
Recommendations in National Academy of Sciences report may lead to smarter regulation of research.
The politics of regulatory reform is much more about politics than it is about regulation.
Both critics and defenders overstate true role of cost-benefit analysis in rulemaking